Compound brief
Evidence brief. Not treatment advice or a safety clearance. Last evidence update: September 2026.
DAC keeps the analog on albumin, so exposure lasts longer than the no-DAC analog. The pituitary still needs a pulse pattern. Continuous GHRH-receptor occupancy is a different biological situation from a short analog.
CJC-1295 with DAC and modified GRF without DAC are different chemicals.
GHRH receptors on somatotrophs raise cAMP and release growth hormone. DAC holds the analog in circulation on albumin, so the pituitary sees a longer signal than a short GHRH fragment.
The liver answers GH with IGF-1. Glucose can fall when IGF-1 rises. Forums that stack this with ipamorelin are combining GHRH-receptor and ghrelin-receptor inputs into one pulse conversation.
Forum themes are unverified. They do not outrank a study, and they are not a dose.
GHRH plus ghrelin peptide · unverified
The most common forum stack is a GHRH analog with ipamorelin, described as a night-time pulse. That is two receptors and a lot of ritual timing. It is not a published fixed-dose combination in this seed.
Theme summarized from public discussion. Not a quoted post, not a trial, and not a dose.